ROX1 and ERG regulation in Saccharomyces cerevisiae: Implications for antifungal susceptibility

Eukaryotic Cell

Volumn 1, Issue 6, 2002, Pages 1041-1044

  Henry, Karl W ^a,b   Nickels, Joseph T ^a   Edlind, Thomas D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; DNA BINDING PROTEIN; ERGOSTEROL; NAPHTHALENE DERIVATIVE; REPRESSOR PROTEIN; RNA; ROX1 PROTEIN, S CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEIN; TERBINAFINE;

ARTICLE; BIOSYNTHESIS; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SACCHAROMYCES CEREVISIAE; TIME; UPREGULATION;

ANTIFUNGAL AGENTS; DNA-BINDING PROTEINS; ERGOSTEROL; GENE DELETION; GENE EXPRESSION REGULATION, FUNGAL; NAPHTHALENES; REPRESSOR PROTEINS; RNA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TIME FACTORS; UP-REGULATION;

SACCHAROMYCES CEREVISIAE;

EID: 0038671758     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.1.6.1041-1044.2002     Document Type: Article

References (31)

1. Arthington-Skaggs, B. A., D. N. Crowell, H. Yang, S. L. Sturley, and M. Bard. 1996. Positive and negative regulation of a sterol biosynthetic gene (ERG3) in the post-squalene portion of the yeast ergosterol pathway. FEBS Lett. 392:161-165.
2. Bammert, G. F., and J. M. Fostel. 2000. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob. Agents Chemother. 44:1255-1265.
3. Daum, G., N. D. Lees, M. Bard, and R. Dickson. 1998. Biochemistry, cell biology and molecular biology of lipids in Saccharomyces cerevisiae. Yeast 14:1471-1510.
4. De Backer, M. D., T. Ilyina, X.-J. Ma, S. Vandoninck, W. H. M. L. Luyten, and H. Vanden Bossche. 2001. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 45:1660-1670.
5. Deekert, J., R. Perin, B. Balasubramanian, and R. S. Zitomer. 1995. Multiple elements and auto-repression regulate ROX1, a repressor of hypoxic genes in Saccharomyces cerevisiae. Genetics 139:1149-1158.
6. Dimster-Denk, D., and J. Rine. 1996. Transcriptional regulation of a sterolbiosynthetic enzyme by sterol levels in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:3981-3989.
7. Dimster-Denk, D., J. Rine, J. Phillips, S. Scherer, P. Cundiff, K. DeBord, D. Gilliland, S. Hickman, A. Jarvis, L. Tong, and M. Ashby. 1999. Comprehensive evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae utilizing the Genome Reporter Matrix™. J. Lipid Res. 40:850-860.
8. Geber, A., C. A. Hitchcock, J. E. Swartz, F. S. Pullen, K. E. Marsden, K. J. Kwon-Chung, and J. E. Bennett. 1995. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal sensitivity. Antimicrob. Agents Chemother. 39:2708-2717.
9. Henry, K. W., M. C. Cruz, S. K. Katiyar, and T. D. Edlind. 1999. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents. Antimicrob. Agents Chemother. 43:1968-1974.
10. Henry, K. W., J. T. Nickels, and T. D. Edlind. 2000. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob. Agents Chemother. 44:2693-2700.
11. Kadosh, D., and A. D. Johnson. 2001. Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol. Cell. Biol. 21:2496-2505.
12. Kastaniotis, A. J., and R. S. Zitomer. 2000. Rox1 mediated repression. Oxygen dependent repression in yeast. Adv. Exp. Med. Biol. 475:185-195.
13. Kennedy, M. A., R. Barbuch, and M. Bard. 1999. Transcriptional regulation of the squalene synthase gene (ERG9) in the yeast Saccharomyces cerevisiae. Biochim. Biophys. Acta 1445:110-122.
14. Khalaf, R. A., and R. S. Zitomer. 2001. The DNA binding protein Rfg1 is a repressor of filamentation in Candida albicans. Genetics 157:1503-1512.
15. Kwast, K. E., L.-C. Lai, N. Menda, D. T. James III, S. Aref, and P. V. Burke. 2002. Genomic analyses of anaerobically induced genes in Saccharomyces cerevisiae: functional roles of Rox1 and other factors in mediating the anoxic response. J. Bacteriol. 184:250-265.
16. Lees, N. D., M. Bard, and D. R. Kirsch. 1999. Biochemistry and molecular biology of sterol synthesis in Saccharomyces cerevisiae. Crit. Rev. Biochem. Mol. Biol. 34:33-47.
17. Longtine, M. S., A. MeKenzie, D. J. Demarini, N. G. Shah, A. Waeh, A. Brachat, P. Philippsen, and J. R. Pringle. 1998. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14:953-961.
18. Lupetti, A., R. Danesi, M. Campa, M. Del Tacca, and S. Kelly. 2002. Molecular basis of resistance to azole antifungals. Trends Mol. Med. 8:76-81.
19. M'Baya, B., M. Fegueur, M. Servouse, and F. Karst. 1989. Regulation of squalene synthetase and squalene epoxidase activities in Saccharomyces cerevisiae. Lipids 24:1020-1023.
20. Perea, S., J. L. López-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillán, M. Martínez, D. Calabrese, D. Sanglard, and T. F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45:2676-2684.
21. Revankar, S. G., W. R. Kirkpatrick, R. K. McAtee, A. W. Fothergill, S. W. Redding, M. G. Rinaldi, and T. F. Patterson. 1998. Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method. J. Clin. Microbiol. 36:153-156.
22. Rex, J. H., P. W. Nelson, V. L. Paetznick, M. Lozano-Chiu, A. Espinel-Ingroff, and E. J. Anaissie. 1998. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 42:129-134.
23. Ruhnke, M., A. Sehmidt-Westhausen, E. Engelmann, and M. Trautmann. 1996. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy. J. Clin. Microbiol. 34:3208-3211.
24. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
25. Smith, S. J., J. H. Crowley, and L. W. Parks. 1996. Transcriptional regulation by ergosterol in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 16:5427-5432.
26. Soustre, I., P.-H. Dupuy, S. Silve, F. Karst, and G. Loison. 2000. Sterol metabolism and ERG2 gene regulation in the yeast Saccharomyces cerevisiae. FEBS Lett. 470:102-106.
27. Ter Linde, J. J. M., and H. Y. Steensma. 2002. A microarray-assisted screen for potential Hap1 and Rox1 target genes in Saccharomyces cerevisiae. Yeast 19:825-840.
28. Turi, T. G., and J. C. Loper. 1992. Multiple regulatory elements control expression of the gene encoding the Saccharomyces cerevisiae cytochrome P450, Ianosterol 14α-demethylase (ERG11). J. Biol. Chem. 267:2046-2056.
29. White, T. C., S. Holleman, F. Dy, L. F. Mirels, and D. A. Stevens. 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46:1704-1713.
30. Zitomer, R. S., M. P. Limback, A. M. Rodriguez-Torres, B. Balasubramanian, J. Deckert, and P. M. Snow. 1997. Approaches to the study of Rox1 repression of the hypoxic genes in the yeast Saccharomyces cerevisiae. Methods 11:279-288.
31. Zitomer, R. S., and C. V. Lowry. 1992. Regulation of gene expression by oxygen in Saccharomyces cerevisiae. Microbiol. Rev. 56:1-11.